Tags: Coronavirus | bayer | malaria | coronavirus

Bayer Donates 3M Malaria Tablets to US Coronavirus Fight

Bayer Donates 3M Malaria Tablets to US Coronavirus Fight
(Maja Hitij/Getty Images)

Thursday, 19 March 2020 01:29 PM

Bayer AG said on Thursday it has donated 3 million tablets of the malaria drug Resochin to the U.S. government for potential use to treat COVID-19.

Resochin, made of chloroquine phosphate and an approved treatment for malaria, is being evaluated in China for its potential use against COVID-19, the disease caused by the fast-spreading coronavirus.

Bayer said the drug is currently not approved for use in the United States and the company is working with appropriate agencies on an emergency use authorization for its use in the United States.

U.S. President Donald Trump, speaking at a news conference on Thursday, called on U.S. health regulators to expedite potential therapies such as Gilead Sciences Inc's Remdesivir and the generic antimalarial drug hydroxychloroquine, aimed at treating COVID-19.

© 2020 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Health-News
Bayer AG said on Thursday it has donated 3 million tablets of the malaria drug Resochin to the U.S. government for potential use to treat COVID-19.
bayer, malaria, coronavirus
125
2020-29-19
Thursday, 19 March 2020 01:29 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved